| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,484 | 180 | 902 | 953 | | Cost of Revenue | 239 | 163 | 185 | 44 | | | Gross Profit | 1,245 | 17 | 717 | 908 | | | Operating Expenses | | Research Development | 2,220 | 2,268 | 3,028 | 3,219 | | Selling General and Administrative | 2,762 | 3,377 | 3,428 | 2,986 | | Non Recurring |
-
|
-
|
-
| (1,722) | | Others | 503 | 857 | 733 | 2,544 | | | | Total Operating Expenses |
-
|
-
|
-
| 7,026 | | | | Operating Income or Loss | (4,240) | (6,485) | (6,472) | (6,118) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 814 | 50 | 49 | 78 | | Earnings Before Interest And Taxes | (3,426) | (6,435) | (6,423) | (5,984) | | Interest Expense | (31) | 13 | 18 | 24 | | Income Before Tax | (3,395) | (6,448) | (6,441) | (6,008) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest | 189 | (56) | 56 | 55 | | | | Net Income From Continuing Ops | (3,206) | (6,504) | (6,385) | (6,008) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (3,206) | (6,504) | (6,385) | (6,008) | | Preferred Stock And Other Adjustments | (111) | 111 |
-
|
-
| | | Net Income Applicable To Common Shares | ($3,317) | ($6,393) | ($6,385) | ($6,008) |
|
0.51% Nasdaq 
Income Statement
